Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Clearstream successfully launches Vestima+ Funds

24.01.2005


Widespread market support expected to grow in 2005 as coverage expands

Clearstream announced on Monday that it has successfully launched its new Vestima+ Investment Funds service and that transactions in international markets were flowing as expected following an implementation project over the weekend.

The Vestima+ service is targeting the differing needs of each of Europe’s main domestic distributors and provides a single solution for multiple fund markets. The main features of the service include near-100-percent straight-through processing (STP) and the ability for fund distributors to select their preferred settlement mode, delivery versus payment (DVP) or free of payment (FOP) and to choose their own optimal settlement route and custody providers. Clearstream is now evaluating expanding the service to other markets such as Italy and the UK.

The benefits of the service and the open settlement model have been readily accepted by many major market participants with a steady stream of organizations signing up for the service throughout the last year. This trend is expected to continue and will create important automated volumes in domestic markets as cost efficiency benefits of over 50 percent are possible.

Clearstream has worked with market participants to design the service enabling customers to leverage their existing domestic infrastructures in order to reach the highest cost reductions level. Through Vestima+, and for the first time in the fund market, customers can select wherever they wish to settle and whether to use or not Clearstream’s integrated settlement and custody services.

Jeffrey Tessler, CEO of Clearstream International stated, "The success of the Vestima+ launch represents the first milestone of a collaborative process of working with market participants to create a solution that meets their needs. As a result, the service is open, unique, innovative and delivers cost-efficiency where our customers need it most. Now we will look forward to expanding its market coverage."

Yolande Theis and Graham Cope will be happy to answer questions from the news desks: phone +352-243-31500

media-relations | Deutsche Boerse Group
Further information:
http://www.deutsche-boerse.com

More articles from Business and Finance:

nachricht Microtechnology industry is hiring – positive developments of past years continue
09.04.2018 | IVAM Fachverband für Mikrotechnik

nachricht RWI/ISL-Container Throughput Index with minor decline on a high overall level
20.03.2018 | RWI – Leibniz-Institut für Wirtschaftsforschung

All articles from Business and Finance >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>